NICHOLAS GELORMINI: Open Payments
NPI 1992970248 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 8 payments from 5 companies in 2025. Trend: 2023 $88 · 2024 $245 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
Products named: REXULTI, INGREZZA, VRAYLAR, COBENFY, FANAPT.
Industry payments across RI — which companies pay providers there.
